AgeX Therapeutics logo
AgeX Therapeutics AGE
report update icon

Quartalsbericht 2026-Q3
hinzugefügt 12.11.2026

AgeX Therapeutics ROE | AGE

ROE Jährlich AgeX Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
51843.24 -1738.07 -16.32 60.78 73.32 -39.09 -464.42 -91.14 - 66.15 - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
51843.24 -1738.07 5521.61

ROE Vierteljährlich AgeX Therapeutics

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
8972.39 8735.21 8384.05 8114.67 -1540.92 -1257.14 -890.04 -528.42 7.7 12.64 42.09 -15.39 9.5 30.84 52.87 34.11 -5.7 -2.18 7.92 -1.38 -27.83 21.05 119.91 1011.75 951.63 816.87 645.57 -354.88 -279.03 -238.65 -199.21 -57.96 -28.88 -25.92 -3.16 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
8972.39 -1540.92 928.97

ROE anderer Aktien in der Pharmaeinzelhändler

Name ROE Preis % 24h Marktkapitalisierung Land
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
103.22 - -2.5 % $ 5.88 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
6.58 - 0.49 % $ 251 B cayman-islandsCayman-islands
EyePoint Pharmaceuticals EyePoint Pharmaceuticals
EYPT
-75.78 $ 0.23 -12.11 % $ 16.8 K usaUSA
Bio-Path Holdings Bio-Path Holdings
BPTH
-6424.68 - - $ 100 K usaUSA
Cara Therapeutics Cara Therapeutics
CARA
-86.94 - -3.03 % $ 260 M usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
22.71 - -0.88 % $ 598 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
-114.44 - -16.75 % $ 25.8 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
-5.66 - -5.98 % $ 34.1 M usaUSA
Diffusion Pharmaceuticals Diffusion Pharmaceuticals
DFFN
-148.0 - 11.68 % $ 8.97 M usaUSA
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
49.5 - -5.68 % $ 8.28 M usaUSA
Enochian Biosciences Enochian Biosciences
ENOB
39.47 - - $ 40.5 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
7.51 - - $ 661 M usaUSA
Evofem Biosciences Evofem Biosciences
EVFM
-0.53 - 7.55 % $ 38.1 M usaUSA
Eyenovia Eyenovia
EYEN
-110.36 - 49.81 % $ 13.2 M usaUSA
FibroGen FibroGen
FGEN
-610.73 - - $ 889 M usaUSA
Homology Medicines Homology Medicines
FIXX
70.93 - 0.77 % $ 53.4 M usaUSA
Amicus Therapeutics Amicus Therapeutics
FOLD
-9.89 - - $ 4.47 B usaUSA
Frequency Therapeutics Frequency Therapeutics
FREQ
-227.96 - - $ 528 M usaUSA
Galecto Galecto
GLTO
-87.29 - - $ 762 M danmarkDanmark
GlycoMimetics GlycoMimetics
GLYC
0.08 - 9357.83 % $ 1.01 B usaUSA
Graybug Vision Graybug Vision
GRAY
445.11 - -11.23 % $ 9.65 M usaUSA
Galera Therapeutics Galera Therapeutics
GRTX
3750.6 - -32.59 % $ 7.61 M usaUSA
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
-40.75 - 1.35 % $ 17.8 M chinaChina
Novavax Novavax
NVAX
-344.65 $ 7.47 -3.24 % $ 1.21 B usaUSA
Hepion Pharmaceuticals Hepion Pharmaceuticals
HEPA
-310.32 - -18.79 % $ 39.3 K usaUSA
Hoth Therapeutics Hoth Therapeutics
HOTH
-202.73 - - $ 18.8 M usaUSA
IMARA IMARA
IMRA
-22.56 - 15.96 % $ 663 M usaUSA
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
4039.1 - - $ 1.45 B britainBritain
KemPharm KemPharm
KMPH
53.82 - -0.34 % $ 200 M usaUSA
Kezar Life Sciences Kezar Life Sciences
KZR
-79.96 - - $ 53.3 M usaUSA
Lixte Biotechnology Holdings Lixte Biotechnology Holdings
LIXT
-62.9 - - $ 63.4 M usaUSA
Magenta Therapeutics Magenta Therapeutics
MGTA
-32.9 - -7.74 % $ 41.6 M usaUSA
NovaBay Pharmaceuticals NovaBay Pharmaceuticals
NBY
99.84 - - $ 11.3 M usaUSA
NeuroBo Pharmaceuticals NeuroBo Pharmaceuticals
NRBO
-243.26 - 0.43 % $ 12 M usaUSA
OncoCyte Corporation OncoCyte Corporation
OCX
0.16 - 17.22 % $ 355 K usaUSA
Onconova Therapeutics Onconova Therapeutics
ONTX
-1457.87 - -0.47 % $ 21 M usaUSA
Opthea Limited Opthea Limited
OPT
80.96 - - $ 1.2 B australiaAustralia
Verastem Verastem
VSTM
-366.23 $ 6.33 -7.8 % $ 439 M usaUSA
BiomX BiomX
PHGE
2780.26 $ 1.85 14.2 % $ 3.02 M israelIsrael
Pieris Pharmaceuticals Pieris Pharmaceuticals
PIRS
-149.07 - -15.58 % $ 1.22 B germanyGermany
Plus Therapeutics Plus Therapeutics
PSTV
-560.21 - - $ 301 M usaUSA
Pluristem Therapeutics Pluristem Therapeutics
PSTI
103.41 - -1.9 % $ 33.3 M israelIsrael
Qualigen Therapeutics Qualigen Therapeutics
QLGN
-60.7 - 5.59 % $ 1.16 M usaUSA
Qilian International Holding Group Limited Qilian International Holding Group Limited
QLI
-5.1 - -6.08 % $ 184 M chinaChina
Cassava Sciences Cassava Sciences
SAVA
-122.27 - - $ 110 M usaUSA
Selecta Biosciences Selecta Biosciences
SELB
103.22 - -8.69 % $ 126 M usaUSA
Sangamo Therapeutics Sangamo Therapeutics
SGMO
861.59 - - $ 50.4 M usaUSA
Salarius Pharmaceuticals Salarius Pharmaceuticals
SLRX
-212.58 - - $ 2.64 M usaUSA
Sensei Biotherapeutics Sensei Biotherapeutics
SNSE
-113.41 - - $ 17.5 M usaUSA
Sonnet BioTherapeutics Holdings Sonnet BioTherapeutics Holdings
SONN
-148.43 - - $ 826 K usaUSA